GGrantIndex
← Leaderboards

Corey Casper

Fred Hutchinson Cancer Center

Google Scholar ↗PubMed ↗ORCID ↗
$15,901,770
Attributed
$20,632,270
Total exposure
17
Grants
15
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.3M · FY2005–24
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$24,727,413 · 18

By mechanism

R01$9,676,356 · 3
U54$8,190,287 · 7
P30$2,853,753 · 3
D43$2,768,716 · 2
K23$736,940 · 1
U19$501,361 · 2

Top collaborators

Most similar at Fred Hutchinson Cancer Center

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms”

Research focus

Malignant NeoplasmsUgandaInstitutesAcquired Immunodeficiency SyndromeSiteNatural HistorySpecimenProgramsTumorLeadResearch PersonnelHiv InfectionsAfrica South Of The SaharaPersonsInfectionAfricaCohortCountryBaseMemberCollaborationsDesignTrainingIncidence

Grant awards (88)

Scientific Core One$126,171
U19 · FY2024 · AI · contact PI
Scientific Core One$375,190
U19 · FY2023 · AI · contact PI
Core K: HIV-Associated Malignancies$348,857
P30 · FY2022 · AI · contact PI
Core K: HIV-Associated Malignancies$319,099
P30 · FY2021 · AI · contact PI
HIV integration-mediated modulation of immune regulation in HPV-associated cancers$1,365,545
R01 · FY2020 · CA
Core K: HIV-Associated Malignancies$370,194
P30 · FY2020 · AI · contact PI
HIV integration-mediated modulation of immune regulation in HPV-associated cancers$1,423,275
R01 · FY2019 · CA
Core K: HIV-Associated Malignancies$334,611
P30 · FY2019 · AI · contact PI
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda$295,105
U54 · FY2019 · CA
Core A - Administration$88,200
U54 · FY2019 · CA · contact PI
Research Program: Global Oncology$87,210
P30 · FY2019 · CA · contact PI
Core C - Clinical Research and Biorepository$85,019
U54 · FY2019 · CA · contact PI
Project 1$52,995
U54 · FY2019 · CA · contact PI
Project 3$34,952
U54 · FY2019 · CA · contact PI
Project 2$33,939
U54 · FY2019 · CA · contact PI
Research Program: Global Oncology$9,134
P30 · FY2019 · CA · contact PI
Research Program: Global Oncology$7,406
P30 · FY2019 · CA · contact PI
Research Program: Global Oncology$3,703
P30 · FY2019 · CA · contact PI
Research Program: Global Oncology$2,890
P30 · FY2019 · CA · contact PI
HIV integration-mediated modulation of immune regulation in HPV-associated cancers$1,434,093
R01 · FY2018 · CA
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda$737,761
U54 · FY2018 · CA
Core K: HIV-Associated Malignancies$290,484
P30 · FY2018 · AI · contact PI
Project 1$273,541
U54 · FY2018 · CA · contact PI
Core C - Clinical Research and Biorepository$222,032
U54 · FY2018 · CA · contact PI
Project 2$111,683
U54 · FY2018 · CA · contact PI
Research Program: Global Oncology$87,209
P30 · FY2018 · CA · contact PI
Core A - Administration$75,359
U54 · FY2018 · CA · contact PI
Project 3$55,147
U54 · FY2018 · CA · contact PI
Research Program: Global Oncology$9,134
P30 · FY2018 · CA · contact PI
Research Program: Global Oncology$8,333
P30 · FY2018 · CA · contact PI
Research Program: Global Oncology$7,406
P30 · FY2018 · CA · contact PI
Research Program: Global Oncology$2,890
P30 · FY2018 · CA · contact PI
Research Program: Global Oncology$1,234
P30 · FY2018 · CA · contact PI
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda$738,290
U54 · FY2017 · CA
HIV integration-mediated modulation of immune regulation in HPV-associated cancers$622,563
R01 · FY2017 · CA
HIV-Associated Malignancies (HIVAM)$295,992
P30 · FY2017 · AI · contact PI
Project 1$268,942
U54 · FY2017 · CA · contact PI
Core C - Clinical Research and Biorepository$239,148
U54 · FY2017 · CA · contact PI
Research Program: Global Oncology$119,013
P30 · FY2017 · CA · contact PI
Project 2$113,160
U54 · FY2017 · CA · contact PI
Core A - Administration$66,308
U54 · FY2017 · CA · contact PI
Project 3$50,732
U54 · FY2017 · CA · contact PI
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda$743,281
U54 · FY2016 · CA
HIV integration-mediated modulation of immune regulation in HPV-associated cancers$692,917
R01 · FY2016 · CA
Expanding independent research capacity in HIV-associated malignancies in Uganda$303,180
D43 · FY2016 · TW · contact PI
Project 1$265,393
U54 · FY2016 · CA · contact PI
Core C - Clinical Research and Biorepository$243,777
U54 · FY2016 · CA · contact PI
Project 2$110,279
U54 · FY2016 · CA · contact PI
Research Program: Global Oncology$87,231
P30 · FY2016 · CA · contact PI
Core A - Administration$76,299
U54 · FY2016 · CA · contact PI
Project 3$47,533
U54 · FY2016 · CA · contact PI
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda$830,706
U54 · FY2015 · CA · contact PI
Novel Pathogen Associated Cancers (PQ12)$371,081
R01 · FY2015 · CA
Expanding independent research capacity in HIV-associated malignancies in Uganda$302,463
D43 · FY2015 · TW · contact PI
Core C - Clinical Research and Biorepository$295,913
U54 · FY2015 · CA · contact PI
Project 1$294,552
U54 · FY2015 · CA · contact PI
Project 2$108,401
U54 · FY2015 · CA · contact PI
Research Program: Global Oncology$89,613
P30 · FY2015 · CA · contact PI
Core A - Administration$80,379
U54 · FY2015 · CA · contact PI
Project 3$51,461
U54 · FY2015 · CA · contact PI
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda$750,000
U54 · FY2014 · CA · contact PI
Novel Pathogen Associated Cancers (PQ12)$722,856
R01 · FY2014 · CA
Expanding independent research capacity in HIV-associated malignancies in Uganda$304,560
D43 · FY2014 · TW · contact PI
Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in Africa$297,622
R01 · FY2014 · CA · contact PI
Core C - Clinical Research and Biorepository$252,875
U54 · FY2014 · CA · contact PI
Project 1$249,362
U54 · FY2014 · CA · contact PI
Project 2$96,488
U54 · FY2014 · CA · contact PI
Core A - Administration$63,921
U54 · FY2014 · CA · contact PI
Project 3$45,891
U54 · FY2014 · CA · contact PI
Core B - Career Development$41,463
U54 · FY2014 · CA · contact PI
Novel Pathogen Associated Cancers (PQ12)$736,412
R01 · FY2013 · CA
HIV-Associated Malignancies (HIVAM)$372,110
P30 · FY2013 · AI · contact PI
Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in Africa$282,976
R01 · FY2013 · CA · contact PI
Building Sustainable Translational Research Teams in HIV-Associated Malignancies$250,000
D43 · FY2013 · CA · contact PI
Novel Pathogen Associated Cancers (PQ12)$784,723
R01 · FY2012 · CA
Building Sustainable Translational Research Teams in HIV-Associated Malignancies$535,371
D43 · FY2012 · CA · contact PI
Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in Africa$297,837
R01 · FY2012 · CA · contact PI
Building Sustainable Translational Research Teams in HIV-Associated Malignancies$535,506
D43 · FY2011 · CA · contact PI
Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in Africa$297,775
R01 · FY2011 · CA · contact PI
Building Sustainable Translational Research Teams in HIV-Associated Malignancies$537,636
D43 · FY2010 · CA · contact PI
Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in Africa$346,681
R01 · FY2010 · CA · contact PI
HHV-8 Transmission Among Men Who Have Sex with Men$54,000
K23 · FY2008 · AI · contact PI
HHV-8 Transmission Among Men Who Have Sex with Men$125,820
K23 · FY2007 · AI · contact PI
HHV-8 Transmission Among Men Who Have Sex with Men$54,000
K23 · FY2007 · AI · contact PI
HHV-8 Transmission Among Men Who Have Sex with Men$125,820
K23 · FY2006 · AI · contact PI
HHV-8 Transmission Among Men Who Have Sex with Men$125,820
K23 · FY2005 · AI
HHV-8 Transmission Among Men Who Have Sex with Men$125,820
K23 · FY2004 · AI
HHV-8 Transmission Among Men Who Have Sex with Men$125,660
K23 · FY2003 · AI